المؤلفون: S. V. Belmer, С. В. Бельмер

المصدر: Meditsinskiy sovet = Medical Council; № 17 (2023); 143-148 ; Медицинский Совет; № 17 (2023); 143-148 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: спазмолитики, pathogenesis, treatment, probiotics, synbiotics, trimebutine, antispasmodics, патогенез, лечение, пробиотики, синбиотики, тримебутин

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7833/6954; Бельмер СВ, Волынец ГВ, Горелов АВ, Гурова ММ, Звягин АА, Корниенко ЕА и др. Функциональные расстройства органов пищеварения у детей. Рекомендации Общества детских гастроэнтерологов, гепатологов и нутрициологов. Часть 2. Российский вестник перинатологии и педиатрии. 2020;65(5):100–111. https://doi.org/10.21508/1027-4065-2020-65-5-100-111.; Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology. 2016;150(6):P1262–1279.E2. https://doi.org/10.1053/j.gastro.2016.02.032.; Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional Disorders: Children and Adolescents. Gastroenterology. 2016;150(6):P1456-1468.E2. https://doi.org/10.1053/j.gastro.2016.02.015.; Thapar N, Benninga MA, Crowell MD, Di Lorenzo C, Mack I, Nurko S et al. Paediatric functional abdominal pain disorders. Nat Rev Dis Primers. 2020;6(1):89. https://doi.org/10.1038/s41572-020-00222-5.; Adriani A, Ribaldone DG, Astegiano M, Durazzo M, Saracco GM, Pellicano R. Irritable bowel syndrome: the clinical approach. Panminerva Med. 2018;60(4):213–222. https://doi.org/10.23736/S0031-0808.18.03541-3.; Xiao L, Liu Q, Luo M, Xiong L. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome. Front Cell Infect Microbiol. 2021;11:729346. https://doi.org/10.3389/fcimb.2021.729346.; Salem AE, Singh R, Ayoub YK, Khairy AM, Mullin GE. The gut microbiome and irritable bowel syndrome: State of art review. Arab J Gastroenterol. 2018;19(3):136–141. https://doi.org/10.1016/j.ajg.2018.02.008.; Pickard JM, Zeng MY, Caruso R, Núñez G. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. 2017;279(1):70–89. https://doi.org/10.1111/imr.12567.; Sorbara MT, Pamer EG. Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them. Mucosal Immunol. 2019;12(1):1–9. https://doi.org/10.1038/s41385-018-0053-0.; Mishima Y, Ishihara S. Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome. Int J Mol Sci. 2020;21(22):8664. https://doi.org/10.3390/ijms21228664.; Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients. 2017;9(9):940. https://doi.org/10.3390/nu9090940.; Barandouzi ZA, Lee J, Maas K, Starkweather AR, Cong XS. Altered Gut Microbiota in Irritable Bowel Syndrome and Its Association with Food Components. J Pers Med. 2021;11(1):35. https://doi.org/10.3390/jpm11010035.; Zhan K, Zheng H, Li J, Wu H, Qin S, Luo L, Huang S. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome. Biomed Res Int. 2020:3828249. https://doi.org/10.1155/2020/3828249.; Harris LA, Baffy N. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Postgrad Med. 2017;129(8):872–888. https://doi.org/10.1080/00325481.2017.1383819.; Sundin J, Öhman L, Simrén M. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases. Psychosom Med. 2017;79(8):857–867. https://doi.org/10.1097/PSY.0000000000000470.; Shankar V, Agans R, Holmes B, Raymer M, Paliy O. Do gut microbial communities differ in pediatric IBS and health? Gut Microbes. 2013;4(4):347–352. https://doi.org/10.4161/gmic.24827.; Shariati A, Fallah F, Pormohammad A, Taghipour A, Safari H, Chirani AS et al. The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome. J Cell Physiol. 2019;234(6):8550–8569. https://doi.org/10.1002/jcp.27828.; Aziz MNM, Kumar J, Muhammad Nawawi KN, Raja Ali RA, Mokhtar NM. Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain. Nutrients. 2021;13(9):3061. https://doi.org/10.3390/nu13093061.; Wei W, Wang HF, Zhang Y, Zhang YL, Niu BY, Yao SK. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol. 2020;26(45):7153–7172. https://doi.org/10.3748/wjg.v26.i45.7153.; Moser G, Fournier C, Peter J. Intestinal microbiome-gut-brain axis and irritable bowel syndrome. Wien Med Wochenschr. 2018;168(3-4):62–66. https://doi.org/10.1007/s10354-017-0592-0.; Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol. 2017;312(1):G52–G62. https://doi.org/10.1152/ajpgi.00338.2016.; Cryan JF, O’Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M et al. The Microbiota-Gut-Brain Axis. Physiol Rev. 2019;99(4):1877–2013. https://doi.org/10.1152/physrev.00018.2018.; Shrestha B, Patel D, Shah H, Hanna KS, Kaur H, Alazzeh MS et al. The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review. Cureus. 2022;14(8):e28064. https://doi.org/10.7759/cureus.28064.; Rexwinkel R, Vlieger AM, Saps M, Tabbers MM, Benninga MA. A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified. Eur J Pediatr. 2022;181(7):2603–2617. https://doi.org/10.1007/s00431-022-04459-y.; Schechter NL, Coakley R, Nurko S. The Golden Half Hour in Chronic Pediatric Pain-Feedback as the First Intervention. JAMA Pediatr. 2021;175(1):7–8. https://doi.org/10.1001/jamapediatrics.2020.1798.; Бельмер СВ, Хавкин АИ, Печкуров ДВ. Функциональные расстройства органов пищеварения у детей. Принципы диагностики и лечения (международные и отечественные рекомендации). М.: ГЭОТАР-Медиа; 2020. 224 с.; Abbott RA, Martin AE, Newlove-Delgado TV, Bethel A, Thompson-Coon J, Whear R, Logan S. Psychosocial interventions for recurrent abdominal pain in childhood. Cochrane Database Syst Rev. 2017;1(1):CD010971. https://doi.org/10.1002/14651858.CD010971.pub2.; Turco R, Salvatore S, Miele E, Romano C, Marseglia GL, Staiano A. Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics. Ital J Pediatr. 2018;44(1):53. https://doi.org/10.1186/s13052-018-0495-8.; Boradyn KM, Przybyłowicz KE, Jarocka-Cyrta E. Low FODMAP Diet Is Not Effective in Children with Functional Abdominal Pain: A Randomized Controlled Trial. Ann Nutr Metab. 2020;76(5):334–344. https://doi.org/10.1159/000510795.; Scarpellini E, Giorgio V, Gabrielli M, Filoni S, Vitale G, Tortora A et al. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2013;17(10):1314–1320. Available at: https://www.europeanreview.org/article/3654.; Bogovič Matijašić B, Obermajer T, Lipoglavšek L, Sernel T, Locatelli I, Kos M et al. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial. J Dairy Sci. 2016;99(7):5008– 5021. https://doi.org/10.3168/jds.2015-10743.; Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial. Scand J Gastroenterol. 2011;46(6):663–672. https://doi.org/10.3109/00365521.2011.565066.; Jafari E, Vahedi H, Merat S, Momtahen S, Riahi A. Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating. Arch Iran Med. 2014;17(7):466–470. Available at: https://pubmed.ncbi.nlm.nih.gov/24979556/.; Friedman G. A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients: a Multi-Center, Randomized, Double-Blind Placebo Controlled Study. Am J Gastroenterol. 2008;103(Suppl.):S455. Available at: https://journals.lww.com/ajg/fulltext/2008/09001/a_multi_strain_probiotic_reduces_the_frequency_of.1166.aspx.; Mokhtar NM, Jaafar NM, Alfian E, Mohd Rathi ND, Abdul Rani R, Raja Ali RA. Clinical assessment and cytokines level in constipationpredominant irritable bowel syndrome participants treated with Lactobacillus-containing cultured milk drink. Acta Gastroenterol Belg. 2021;84(4):585–591. https://doi.org/10.51821/84.4.009.; Zhang Y, Li L, Guo C, Mu D, Feng B, Zuo X, Li Y. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol. 2016;16(1):62. https://doi.org/10.1186/s12876-016-0470-z.; Нижевич АА, Гимазетдинова РШ, Туйгунов ММ, Якупова ГМ, Алянгин ВГ. Синдром избыточного бактериального роста при синдроме раздраженного кишечника у детей: возможности пробиотической коррекции. Вопросы практической педиатрии. 2019;14(6):21–28. https://doi.org/10.20953/1817-7646-2019-6-21-28.; Goldin BR, Gorbach SL. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J Natl Cancer Inst. 1980;64(2):263–265. https://doi.org/10.1093/jnci/64.2.263.; Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci. 1992;37(1):121–128. https://doi.org/10.1007/BF01308354.; Scalabrin D, Harris C, Johnston WH, Berseth CL. Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up. Eur J Pediatr. 2017;176(2):217–224. https://doi.org/10.1007/s00431-016-2825-4.; Lundelin K, Poussa T, Salminen S, Isolauri E. Long-term safety and efficacy of perinatal probiotic intervention: Evidence from a follow-up study of four randomized, double-blind, placebo-controlled trials. Pediatr Allergy Immunol. 2017;28(2):170–175. https://doi.org/10.1111/pai.12675.; Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther. 2011;33(12):1302–1310. https://doi.org/10.1111/j.1365-2036.2011.04665.x.; Korterink J, Devanarayana NM, Rajindrajith S, Vlieger A, Benninga MA. Childhood functional abdominal pain: mechanisms and management. Nat Rev Gastroenterol Hepatol. 2015;12(3):159–171. https://doi.org/10.1038/ nrgastro.2015.21.; Balemans D, Mondelaers SU, Cibert-Goton V, Stakenborg N, AguileraLizarraga J, Dooley J et al. Evidence for long-term sensitization of the bowel in patients with post-infectious-IBS. Sci Rep. 2017;7(1):13606. https://doi.org/10.1038/s41598-017-12618-7.; Ивашкин ВТ, Маев ИВ, Шелыгин ЮА, Баранская ЕК, Белоус СС, Белоусова ЕА и др. Диагностика и лечение синдрома раздраженного кишечника (Клинические рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021;31(5):74–95. https://doi.org/10.22416/1382-4376-2021-31-5-74-95.; Горелов АВ, Захарова ИН, Хавкин АИ, Кафарская ЛИ, Усенко ДВ, Бельмер СВ и др. Резолюция Совета экспертов «Дисбиоз. Ближайшие и отдаленные последствия нарушения микробиома и варианты их коррекции с помощью пробиотиков». Вопросы практической педиатрии. 2022;17(1):213–221. https://doi.org/10.20953/1817-7646-2022-1-213-221.; Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48(10):1044–1060. https://doi.org/10.1111/apt.15001.; Hungin APS, Mitchell CR, Whorwell P, Mulligan C, Cole O, Agréus L et al. Systematic review: probiotics in the management of lower gastrointestinal symptoms – an updated evidence-based international consensus. Aliment Pharmacol Ther. 2018;47(8):1054–1070. https://doi.org/10.1111/apt.14539.; Zhang T, Zhang C, Zhang J, Sun F, Duan L. Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network MetaAnalysis. Front Cell Infect Microbiol. 2022;12:859967. https://doi.org/10.3389/fcimb.2022.859967.; Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2011;(8):CD003460. https://doi.org/10.1002/14651858.CD003460.pub3.; Sandhu BK, Paul SP. Irritable bowel syndrome in children: pathogenesis, diagnosis and evidence-based treatment. World J Gastroenterol. 2014;20(20):6013–6023. https://doi.org/10.3748/wjg.v20.i20.6013.; https://www.med-sovet.pro/jour/article/view/7833

الاتاحة: https://www.med-sovet.pro/jour/article/view/7833
https://doi.org/10.21518/ms2023-299

المؤلفون: S. V. Belmer, G. V. Volynets, A. V. Gorelov, M. M. Gurova, A. A. Zvyagin, E. A. Kornienko, V. P. Novikova, D. V. Pechkurov, V. F. Privorotskiy, A. A. Tyazheva, R. A. Faizullina, A. I. Khavkin, S. I. Erdes, С. В. Бельмер, Г. В. Волынец, А. В. Горелов, М. М. Гурова, А. А. Звягин, Е. А. Корниенко, В. П. Новикова, Д. В. Печкуров, В. Ф. Приворотский, А. А. Тяжева, Р. А. Файзуллина, А. И. Хавкин, С. И. Эрдес

المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 65, № 6 (2020); 133-144 ; Российский вестник перинатологии и педиатрии; Том 65, № 6 (2020); 133-144 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2020-65-6

مصطلحات موضوعية: функциональный запор, functional disorders, regurgitations, colic, gastroesophageal reflux, functional dyspepsia, functional abdominal pain, irritable bowel syndrome, biliary dysfunction, functional constipation, функциональные расстройства, срыгивания, колики, гастроэзофагеальный рефлюкс, функциональная диспепсия, функциональная абдоминальная боль, синдром раздраженного кишечника, билиарная дисфункция

وصف الملف: application/pdf

Relation: https://www.ped-perinatology.ru/jour/article/view/1302/1035; Бельмер С.В., Хавкин А.И., Печкуров Д.В. Функциональные нарушения органов пищеварения у детей. Принципы диагностики и лечения (в свете Римских критериев IV). М.: ГЭОТАР-Медиа, 2017; 160. [Belmer S.V., Havkin A.I., Pechkurov D.V. Functional disorders of the digestive system in children. Diagnostic and Treatment Principles (in the Light of Rome IV Criteria). Moscow: GEOTAR-Media, 2017; 160. (in Russ.)]; Drossman D.A., Hasler W.L. Rome IV – Functional GI disorders: disorders of gut-brain interaction. Gastroenterol 2016; 150(6): 1257–1261. DOI:10.1053/j.gastro.2016.03.035; Ивашкин В.Т., Маев И.В., Шульпекова Ю.О., Баранская Е.К., Охлобыстин А.В., Трухманов А.С. и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению дискинезии желчевыводящих путей. Российский журнал гастроэнтерологии, гепатологии, колопроктологии 2018; 28(3): 63–80. DOI:10.22416/1382-4376-2018-28-3-63-80 [Ivashkin V.T., Maev I.V., Shul’pekova Yu.O., Baranskaya E.K., Ohlobystin A.V., Truhmanov A.S. et al. Clinical guidelines of the Russian Gastroenterological Association for the diagnosis and treatment of biliary dyskinesia. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii 2018; 28(3): 63–80. (in Russ.)]; Santucci N.R., Hyman P.E., Harmon C.M. Biliary Dyskinesia in Children: A Systematic Review JPGN. 2017; 64(2): 186– 193. DOI:10.1097/MPG.0000000000001357; Волынец Г. В., Хавкин А.И. Дисфункции билиарного тракта у детей. Медицинский оппонент 2018; 1(3): 59–64. [Volynec G.V., Havkin A.I. Biliary tract dysfunctions in children. Meditsinskij opponent 2018; 1(3): 59–64. (in Russ.)]; Печкуров Д.В., Щербаков П.Л., Каганова Т.И. Синдром диспепсии у детей. М.: МЕДПРАКТИКА-М, 2007; 144. [Pechkurov D.V., Shcherbakov P.L., Kaganova T.I. Dyspepsia syndrome in children. Moscow: MEDPRAKTIKA-M, 2007; 144. (in Russ.)]; Приворотский В.Ф., Луппова Н.Е., Румянцева И.В. Болезни билиарного тракта у детей (этиопатогенез, клиника, диагностика, лечение). Учебное пособие. СПб: Коста, 2015; 101. [Privorotskij V.F., Luppova N.E., Rumyanceva I.V. Diseases of the biliary tract in children (etiopathogenesis, clinical picture, diagnosis, treatment). Textbook. SPb: Kosta, 2015; 101. (in Russ.)]; Детская гастроэнтерология. Под ред. Н.П. Шабалова. М.: Медпресс-информ, 2019; 240–250. [Pediatric gastroenterology. N.P. Shabalov (ed.). Moscow: Medpress-inform, 2019; 240–250. (in Russ.)]; Amaral J., Xiao Z.L., Chen Q, Yu P., Biancani P., Behar J. Gallbladder muscle dysfunction in patients with chronic acalculous disease. Gastroenterol 2001; 120: 506–511. DOI:10.1053/gast.2001.21190; Sharma B.C., Agarwal D.K., Dhiman R.K, Baijal S.S., Choudhuri G., Saraswat V.A. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy. Gastroenterol 1998; 115: 124–128. DOI:10.1016/s0016-5085(98)70373-7; Pasricha P.J. Unraveling the mystery of pain in chronic pancreatitis. Nat Rev Gastroenterol Hepatol 2012; 9: 140–151. DOI:10.1038/nrgastro.2011.274; Li C., Zhu Y., Shenoy M., Pai R., Liu L., Pasricha P.J. Anatomical and functional characterization of a duodeno-pancreatic neural reflex that can induce acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2013; 304: G490–G500. DOI:10.1152/ajpgi.00012.2012; Cotton Р.В., Elta G.H., Carter C.R., Pasricha P.J., Corazziari E.S. Gallbladder and Sphincter of Oddi Disorders. J Gastroenterol 2016; 150(6): 1420–1429. DOI:10.1053/j.gastro.2016.02.033; Ruffolo T.A., Sherman S., Lehman G.A., Hawes R.H. Gallbladder ejection fraction and its relationship to sphincter of Oddi dysfunction. Dig Dis Sci 1994; 39: 289–292. DOI:10.1007/BF02090199; Sood G.K., Baijal S.S., Lahoti D., Broor S.L. Abnormal gallbladder function in patients with irritable bowel syndrome. Am J Gastroenterol 1993; 88: 1387–1390; Pozo M.J., Camello P.J., Mawe G.M. Chemical mediators of gallbladder dysmotility. Curr Med Chem 2004; 11: 1801– 1812 DOI:10.2174/0929867043364955.; Alcon S., Morales S., Camello P.J., Pozo M.J. Contribution of different phospholipases and arachidonic acid metabolites in the response of gallbladder smooth muscle to cholecystokinin. Biochem Pharmacol 2002; 64: 1157–1167. DOI:10.1016/s0006-2952(02)01259-5; Akshintala V.S., Hutfless S.M., Colantuoni E., Kim K.J., Khashab M.A., Li T. et al. Systematic review with network meta-analysis: pharmacologica prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther 2013; 38:1325–1337. DOI:10.1111/apt.12534; Johnson J.J., Garwe T., Katseres N., Tuggle D.W. Preoperative symptom duration predicts success in relieving abdominal pain caused by biliary dyskinesia in a pediatric population. J Pediatr Surg 2013; 48: 796–800. DOI:10.1016/j.jpedsurg.2012.10.047; Carney D.E., Kokoska E.R., Grosfeld J.L., Engum S.A., Rouse T.M., West K.M. et al. Predictors of successful outcome after cholecystectomy for biliary dyskinesia. J Pediatr Surg 2004; 39: 813–816. DOI:10.1016/j.jpedsurg.2004.02.017; Vegunta R.K., Raso M., Pollock J., Misra S., Wallace L.J., Torres A. Jr, Pearl R.H. Biliary dyskinesia: the most common indication for cholecystectomy in children. Surgery 2005; 138: 726–733. DOI:10.1016/j.surg.2005.06.052; Mugie S., Benninga M. A., Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best practice & research. Clin Gastroenterol 2011; 25(1): 3–18. DOI:10.1016/j.bpg.2010.12.010; Loening-Baucke V. Encopresis and soiling. Pediatr Clin North Am 1996; 43(1):279–98. DOI:10.1016/s0031-3955(05)70406-5; Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., Spiller R.C. Functional bowel disorders. Gastroenterol 2006; 130(5): 1480–1491. DOI:10.1053/j.gastro.2005.11.061; Rao S.S., Ozturk R., Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol 2005; 100(7): 1605–1615. DOI:10.1111/j.1572-0241.2005.41845.x; Huang R., Ho S.Y., Lo W.S., Lam T.H. Physical activity and constipation in Hong Kong adolescents. Plos One 2014; 9(2): e901–903. DOI:10.1371/journal.pone.0090193; Robin S.G., Keller C., Zwiener R., Hyman P.E., Nurko S., Saps M. et al. Prevalence of pediatric functional gastrointestinal disorders utilizing the Rome IV criteria. J Pediatr 2018; 195: 134–139. DOI:10.1016/j.jpeds.2017.12.012; Хавкин А.И., Файзуллина Р.А., Бельмер С.В., Горелов А.В., Захарова И.Н., Звягин А.А. и др. Диагностика и тактика ведения детей с функциональными запорами (Рекомендации общества детских гастроэнтерологов). Вопросы детской диетологии 2014; 12(4): 49–65. [Havkin A.I., Fajzullina R.A., Bel’mer S.V., Gorelov A.V., Zaharova I.N., Zvyagin A.A. et al. Diagnostics and management of children with functional constipation (Recommendations of the Society of Pediatric Gastroenterologists). Voprosy detskoi dietologii 2014; 12(4): 49–65. (in Russ.)]; Vandenplas Y., Benninga M., Broekaert I., Falconer J., Gottrand F., Guarino A. et al. Functional gastro‐intestinal disorder algorithms focus on early recognition, parental reassurance and nutritional strategies. Acta Paediatrica 2016; 105(3): 244–252. DOI:10.1111/apa.13270; Хавкин А.И. Коррекция функциональных запоров у детей. Российский вестник перинатологии и педиатрии 2012; 4(1): 127–130. [Khavkin A.I. Correction of functional constipation in children. Rossiyskiy vestnik perinatologii i pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2012; 4(1): 127–130. (in Russ.)]; Hyman P.E., Milla P.J., Benninga M.A., Davidson G.P., Fleisher D.F., Taminiau J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterol 2006; 130(5):1519–26. DOI:10.1053/j.gastro.2005.11.065; Rasquin A., Di Lorenzo C., Forbes D., Guiraldes E., Hyams J.S., Staiano A. et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterol 2006; 130(5):1527–37. DOI:10.1053/j.gastro.2005.08.063; Andrews C.N., Storr M. The pathophysiology of chronic constipation. Can J Gastroenterol 2011; 25 Suppl B:16B–21B.; https://www.ped-perinatology.ru/jour/article/view/1302

الاتاحة: https://www.ped-perinatology.ru/jour/article/view/1302
https://doi.org/10.21508/1027-4065-2020-65-6-133-144

المؤلفون: S. V. Belmer, G. V. Volynets, A. V. Gorelov, M. M. Gurova, A. A. Zvyagin, E. A. Kornienko, V. P. Novikova, D. V. Pechkurov, V. F. Privorotskiy, A. A. Tyazheva, R. А. Fayzullina, A. I. Khavkin, S. I. Erdes, С. В. Бельмер, Г. В. Волынец, А. В. Горелов, М. М. Гурова, А. А. Звягин, Е. А. Корниенко, В. П. Новикова, Д. В. Печкуров, В. Ф. Приворотский, А. А. Тяжева, Р. А. Файзуллина, А. И. Хавкин, С. И. Эрдес

المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 65, № 5 (2020); 100-111 ; Российский вестник перинатологии и педиатрии; Том 65, № 5 (2020); 100-111 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2020-65-5

مصطلحات موضوعية: функциональный запор, functional disorders, regurgitations, colic, gastroesophageal reflux, functional dyspepsia, functional abdominal pain, irritable bowel syndrome, biliary dysfunction, functional constipation, функциональные расстройства, срыгивания, колики, гастроэзофагеальный рефлюкс, функциональная диспепсия, функциональная абдоминальная боль, синдром раздраженного кишечника, билиарная дисфункция

وصف الملف: application/pdf

Relation: https://www.ped-perinatology.ru/jour/article/view/1244/989; Пиманов С.И., Силивончик Н.Н. Римские IV рекомендации по диагностике и лечению функциональных гастроэнтерологических расстройств. Пособие для врачей. М., 2016; 136—137.; Hyams J.S., Di Lorenzo S., Saps M., Shulman R.J., Staiano A., van Tilburg M. Functional gastrointestinal disorders: child / adolescent. Gastroenterol 2016; 150: 1456—1468. DOI: org/10.1053/j.gastro.2016.02.015; Koppen I.J., Nurko S., Saps M., Di Lorenzo C, Bennin-ga M.A. The pediatric Rome IV criteria: what’s new? Expert Rev Gastroenterol Hepatol 2017; 11(3): 193—201. DOI:10.1080/17474124.2017.1282820; Kovacic K., Miranda A., Chelimsky G., Williams S., Simpson P, Li B. Chronic idiopathic nausea of childhood. J Pediatr 2014; 164(5): 1104-1109. DOI:10.1016/j.jpeds.2014.01.046; Saps M., Velasco-Benitez C.A., Langshaw A.H., Ramirez-Hernandez C.R. Prevalence of Functional Gastrointestinal Disorders in Children and Adolescents: Comparison Between Rome III and Rome IV Criteria. J Pediatr 2018; 199: 212-216. DOI:10.1016/j.jpeds.2018.03.037; Singh P., Kuo B. Central Aspects of Nausea and fomiting in GI Disorders. Curr Treat Options Gastroenterol 2016; 14(4): 444-451. DOI:10.1007/s11938-016-0107-x; Trivic I., Hojsak I. Initial Diagnosis of Functional Gastrointestinal Disorders in Children Increases a Chance for Resolution of Symptoms. Pediatr Gastroenterol Hepatol Nutr 2018; 21(4): 264-270. DOI:10.5223/pghn.2018.21.4.264; Canavan C., West J., Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol 2014; 6: 71-80. DOI:10.2147/CLEP.S40245; Shcherbak V.A. The prevalence of Helicobacter pylori infection in children with the syndrome of dyspepsia in the Trans-Baikal Territory. J Pediatric Gastroenterol Nutrit 2017; 64(Suppl.1): 570.; Данные Департамента развития медицинской помощи и курортного дела ФГУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения» Минздрава, 2011. http://mednet.ru/index.php; Печкуров Д.В., Щербаков П.Л., Каганова Т.И. Синдром диспепсии у детей. М., Медпрактика-М 2007; 143.; Печкуров Д.В., Алленова Ю.Е., Тяжева А.А. Содержание интерлейкина-1 в желудочной слизи у детей с функциональной диспепсией. Вопросы детской диетологии 2016; 14(2): 29-31.; Drossman D.A., Hasler W.L. Rome IV - Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterol 2016; 150(6): 1257-1261. DOI:10.1053/j.gastro.2016.03.035; Drossman D.A. The functional gastrointestinal disorders and the Rome III process. Gastroenterol 2006; 130: 1377-1390. DOI:10.1053/j.gastro.2006.03.008; Chitkara D.K., Camilleri M., Zinsmeister A.R., Burton D., El-Youssef M., Freese D. et al. Gastricsensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr 2005; 146: 500-505. DOI:10.1016/j.jpeds.2004.11.031; Feinle-Bisset C., Vozzo R., Horowitz M., Talley N. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99: 170-181. DOI:10.1111/j.1572-0241.2004.04003.x; Akamizu T., Iwakura H., Ariyasu H., Kangawa K. Ghrelin and functional dyspepsia. Int J Peptides 2010; 1: 1-6. DOI:10.1155/2010/548457; Лазебник Л.Б., Ткаченко Е.И., Абдулганиева Д.И., Абдулхаков Р.А., Абдулхаков С.Р., Авалуева Е.Б. и др. VI Национальные рекомендации по диагностике и лечению кислотозависимых и ассоциированных с Helicobacter pylori заболеваний (VI Московские соглашения). Экспериментальная и клиническая гастроэнтерология 2017; 2(138): 3-21.; Jones N.L., Koletzko S., Goodman K., Bontems P., Cad-ranel S., Casswall T. et al. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr 2017; 64(6): 991-1003. DOI:10.1097/MPG.0000000000001594; Нижевич А.А., Валеева Д. С., Сатаев В.У., Гафурова К.А., Ахмадеева Э.Н., Ахметшин Р.З. Современные подходы к лечению функциональной диспепсии в детском возрасте. Вопросы детской диетологии 2017; 15(3): 5-11.; Browne P.D., Nagelkerke S.C.J., van Etten-Jamaludin F.S., Benninga M.A., Tabbers M.M. Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review. Expert Rev Clin Pharmacol 2018; 11(12): 1195-1208. DOI:10.1080/17512433.2018.1540298; PRAC recommends restricting use of domperidone Benefits still considered to outweigh risks when given short-term and in low doses to treat nausea or vomiting 07 March 2014 EMA/129231/2014. The way of access: www.ema.europa.eu; Xiping Z., Hongpeng X. Cerekinon’s effect on esophageal dynamics in patients with endoscopy-negative gastroesophageal reflux disease through esophageal manometry. China Medical Equipment 2007; 8: 16-20.; Aktas A., Caner B., Ozturk F., Bayhan H., Narin Y., Mentes T. The effect of trimebutine maleate on gastric emptying in patients with non-ulcer dyspepsia. Ann Nucl Medicine 1999; 13(4): 231-234. DOI:10.1007/BF03164897; Boige N., Cargill G., Mashako L., Cezard J.P., Navarro J. Trimebutine-induced phase III-like activity in infants with intestinal motility disorders. J Ped Gastroenterol Nutr 1987; 6(4): 548-553. DOI:10.1097/00005176-198707000-00010; Kim B.J., Kuo B. Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment. J Neurogastroenterol Motil 2018; 25(1): 27-35. DOI:10.5056/jnm18162; Keita A.V., Soderholm J.D. Mucosal permeability and mast cells as targets for functional gastrointestinal disorders. Curr Opin Pharmacol 2018; 43: 66-71. DOI:10.1016/j.coph.2018.08.011; Мельцева Е.М., Кулик Е.И., Олексенко Л.Л., Дусале-ева Т.М., Ревенко Н.А. Физические методы лечения функциональной диспепсии у детей. Вестник физиотерапии и курортологии. 2016; 22(4): 49-57.; Казюлин А.Н., Дичева Д.Т., Русс И.С., Андреев Д.Н., Пар-цваниа-Виноградова Е.В. Диетотерапия со сниженным содержанием ферментируемых олигосахаридов, дисахаридов, моносахаридов и полиолов (fodmap) при синдроме раздраженного кишечника. Consilium Medicum 2016, 18(8): 75-78.; Маев И.В., Дичева Д.Т., Андреев Д.Н., Сенина Ю.С. Синдром раздраженного кишечника в практике гастроэнтеролога. В сб.: Актуальные вопросы ведомственной медицины. М., 2012; 83-88. [Maev I.V., Dicheva D.T., Andreev D.N., Senina Yu.S. Irritable bowel syndrome in the practice of a gastroenterologist. In: Topical issues of departmental medicine. Moscow, 2012; 83-88. (in Russ.)]; Lovell R.M., Ford A.C. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-721. DOI:10.1016/j.cgh.2012.02.029; Печкуров Д.В., Алленова Ю.Е., Тяжева А.А. Возрастные особенности функциональных расстройств желудочно-кишечного тракта, проявляющихся абдоминальными болями, с позиций биопсихосоциальной модели. Вопросы детской диетологии 2015; 13(2): 11-15.; Barbara G., Stanghellini V., De Giorgio R., Cremon C., Cottrell G.S., Santini D. et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterol 2004; 126: 693-702. DOI:10.1053/j.gastro.2003.11.055; Ohman L., Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010; 7: 163-173. DOI:10.1038/nr-gastro.2010.4; Johannesson E, Simren M., Strid H, Ringstrom G. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2011; 106: 915-922. DOI:10.1038/ajg.2010.480; Nath A., Haktanirlar G., Varga A., Molnar M.A., Albert K., Galambos I. et al. Biological activities of Lactose-derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal system. Meditsina 2018; 54(2): 18. DOI:10.3390/medici-na54020018; Chen C., Li L., Wu Z., Chen H., Fu S. Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis. J Infect 2007; 54(1): 98-102. DOI:10.1016/j.jinf.2005.11.013; Sperber A.D., Drossman D.A. Review article: the functional abdominal pain syndrome. Aliment Pharmacol Ther 2011; 33: 514-524. DOI:10.1111/j.1365-2036.2010.04561.x; Devanarayana N.M., Mettananda S., Liyanarachchi C., Nan-ayakkara N., Mendis N., Perera N., Rajindrajith S. Abdominal pain-predominant functional gastrointestinal diseases in children and adolescents: prevalence, symptomatology, and association with emotional stress. J Pediatr Gastroenterol Nutr 2011; 53: 659-665. DOI:10.1097/MPG.0b013e3182296033; Clouse R.E., Mayer E.A., Aziz Q-, Drossman D.A., Dumitras-cu D.L., Monnikes El., Naliboff B.D. Functional abdominalpain syndrome. Gastroenterol 2006; 130: 1492—1497. DOI:10.1053/j.gastro.2005.11.062; Yacob D., Di Lorenzo C., Bridge J.A., Rosenstein P.F., Onora-to M., Bravender T., Campo J.V. Prevalence of pain-predominant functional gastrointestinal disorders and somatic symptoms in patients with anxiety or depressive disorders. J Pediatr 2013; 163: 767-770. DOI:10.1016/j.jpeds.2013.02.033; Drossman D.A. The physican-patient relationship. In: Approach to the patient with chronic gastrointestinal disorders. E. Corazziari (ed.). Milano, 2000; 133-139.; Saps M., Youssef N., Miranda A., Hyman P., Cocjin J., Di Lorenzo C. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterol 2009; 137: 1261-1269. DOI:10.1053/j.gastro.2009.06.060; Levy R.L., Langer S.L., Walker L.S., Romano J.M., Christie D.L., Youssef N. et al. Cognitive behavioral therapy for children with functional abdominal pain and their parents decreases pain and other symptoms. Am J Gastroenterol 2010; 105: 946-956. DOI:10.1038/ajg.2010.106; https://www.ped-perinatology.ru/jour/article/view/1244

الاتاحة: https://www.ped-perinatology.ru/jour/article/view/1244
https://doi.org/10.21508/1027-4065-2020-65-5-100-111

المؤلفون: S. V. Belmer, С. В. Бельмер

المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 64, № 6 (2019); 119-125 ; Российский вестник перинатологии и педиатрии; Том 64, № 6 (2019); 119-125 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2019-64-6

مصطلحات موضوعية: функциональные желудочно-кишечные расстройства, milk, fermented milk products, yogurt, lactic acid bacteria, lactobacilli, probiotics, intestinal microflora, functional gastrointestinal disorders, молоко, кисломолочные продукты, йогурт, молочнокислые бактерии, лактобациллы, пробиотики, кишечная микрофлора

وصف الملف: application/pdf

Relation: https://www.ped-perinatology.ru/jour/article/view/1030/882; Swithinbank H., Newman G. Bacteriology of Milk. Editors E. P. Dutton & Co. New York, NY: 1903; 599.; Van Slyke L.L., Hart E.B. Chemical changes in the souring of milk and their relations to cottage cheese. Bulletin (New York Agricultural Experiment Station) 1904; 245–260(245): 46.; Manchester K.L. Louis Pasteur, fermentation, and a rival. S Afr J Sci 2007; 103: 377–380.; Lister J. On the lactic fermentation, and its bearings on pathology. Trans Pathol Soc Lond 1878; 29: 425–467.; Lister J. Further contribution to the natural history of bacteria and the germ theory of fermentative changes. J Cell Sci 1873; s2–13: 380–408.; Orla-Jensen S. The Lactic Acid Bacteria. Mémoires de L’Académie Royale des Sciences et des Lettres de Danemark, Copenhagen, Denmark: 1919.; Schellhaass S.M., Morris H.A. Rheological and scanning electron microscopic examination of skim milk gels obtained by fermenting with ropy and non-ropy strains of lactic acid bacteria. Food Microstruct 1985; 4: 279–287.; Kulp W.L., Rettger L.F. Comparative study of Lactobacillus acidophilus and Lactobacillus bulgaricus. J Bacteriol 1924; 9: 357–395.; Мечников И.И. Этюды оптимизма. Москва: Наука, 1988; 155.; Holzapfel W.H., Haberer P., Geisen R., Björkroth J., Schillinger U. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr 2001; 73(suppl): 365S–373S.; Holzapfel W.H., Haberer P., Snel J., Schillinger U., Huis in’t Veld J.H. Overview of gut flora and probiotics. Int J Food Microbiol 1998; 41: 85–101. DOI:10.1016/s0168-1605(98)00044-0; Orla-Jensen S. Dairy Bacteriology. Editor P.S. Arup. Philadelphia. Blakiston’s Son & Co, 1921; 180.; Pette J.W., Lolkema H. Yoghurt. 1. Symbiosis and antibiosis in mixed cultures of Lactobacillus bulgaricus and Streptococcus thermophilus. Nederlandsch Melken Zuiveltijdschrift 1950; 4: 197–208.; Jankov J., Stoyanov I.V. Study on the thermophilic lactobacilli in milk for yoghurt production. Conference Proceedings XVII International Dairy Congress, Section F5. Munich, Germany 1966; 677–680.; Pette J. W., Kooy J.S. Bacteriophages in yoghurt. Nederlandsch Melken Zuiveltijdschrift 1952; 6: 233–241.; Mocquot G., Hurel C. The selection and use of some microorganisms for the manufacture of fermented and acidified milk products. J Soc Dairy Technol 1970; 23: 130–146.; Cerning J., Bouillanne C., Desmazeaud M.J., Landon M. Isolation and characterization of exocellular polysaccharide produced by Lactobacillus bulgaricus. Biotechnol Lett 1986; 8: 625–628.; Cerning J., Bouillanne C., Desmazeaud M.J., Landon M. Exocellular polysaccharide production by Streptococcus thermophilus. Biotechnol Lett 1988; 10: 255–260.; O’Connor E.B., Barrett E., Fitzgerald G., Hill C., Stanton C., Ross R.P. Production of vitamins, exopolysaccharides and bacteriocins by probiotic bacteria. Probiotic Dairy Products. Editor A.Y. Tamime. Oxford, UK. Blackwell Publishing Ltd., 2005; 167–194.; Pette J.W., Lolkema H. Yoghurt. 3. Acid production and aroma formation in yoghurt. Nederlandsch Melken Zuiveltijdschrift 1950; 4: 261–273.; Dan T., Wang D., Jin R. L., Zhang H.P., Zhou T.T., Sun T.S. Characterization of volatile compounds in fermented milk using solid-phase microextraction methods coupled with gas chromatography-mass spectrometry. J Dairy Sci 2017; 100: 2488–2500. DOI:10.3168/jds.2016-11528; Rašić J., Milanović Z. Influence of Str. Diacetilactisculture on the flavour of yoghurt. Conference Proceedings XVII International Dairy Congress, Section F5, Munich, Germany 1966; 637–642.; Lawrence R.L., Perry G.A. Process for improving the flavor of cultured milk products and the resulting product. Corn Products Company, assignee. US Pat. No. 3,022,176. 1962.; Lilly D.M., Stillwell R.H. Probiotics: Growth-promoting factors produced by microorganisms. Science 1965; 147: 747–748.; FAO/WHO. 2002. Guidelines for the evaluation of probiotics in food. www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf; Vasiljevic T., Shah N.P. Probiotics – from Metchnikoff to bioactives. Int Dairy J 2008; 18: 714–728.; Allen S.J., Martinez E.G., Gregorio G.V., Dans L.F. Probiotics for treating acute infectious diarrhoea. Cochrane Data base Syst Rev 2010; (11): CD003048. DOI:10.1002/14651858.CD003048.pub3; Hume M.E. Historic perspective: Prebiotics, probiotics, and other alternatives to antibiotics. Poult Sci 2011; 90: 2663–2669. DOI:10.3382/ps.2010-01030; Jagielski V.A. Improvement in dietetic compounds from milk. US Pat. No. 117,889. 1871.; Rotch T.M., Kendall A.I. A preparatory study of the bacillus acidophilus in regard to its possible therapeutic use. Am J Dis Child 1911; II(1): 30–38. DOI:10.1001/archpedi.1911.04100070037004; Marriott W.M. The artificial feeding of athreptic infants. JAMA 1919; 73(16): 1173–1177. DOI:10.1001/jama.1919.02610420001001; Marriott W.M., Davidson L.T. Acidified whole milk as a routine infant food. J Am Med Assoc 1923; 81: 2007–2009; Halpern G.M., Vruwink K.G., van de Water J., Keen C.L., Gershwin M.E. Influence of long-term yogurt consumption in young adults. Int J Immunother 1991; 7: 205–210.; Gearing A.J.H., Wadhwa M., Perris A.D. Interleukin 2 stimulates T cell proliferation using a calcium flux. Immunol Lett 1985; 10: 297–302.; Gately M.K., Martz E. Early steps in specific tumor lysis by sensitized mouse T lymphocytes. J Immunol 1979; 122: 482–489.; Goulet J., Saucier L., Moineau S. Stimulation of the non-specific immune response of mice by fermented milks. In: National Yogurt Association, ed. Yogurt: nutritional and health properties. McLean, VA: Kirby Lithographics, 1989; 187–200.; Perdigon G., Nader de Macias M.E., Alvarez S., Oliver G., Pesce de Ruiz Holgado A.A. Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 1988; 63: 17–23.; Sato K., Saito H., Tomioka H. Enhancement of host resistance against Listeria infection by Lactobacillus casei: activation of liver macrophages and peritoneal macrophages by Lactobacillus casei. Microbiol Immunol 1988; 32:689–98. DOI:10.1111/j.1348-0421.1988.tb01430.x; Perdigon G., Nader de Macias M.E., Alvarez S., Oliver G., Pesce de Ruiz Holgado A.A. Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus. J Dairy Sci 1987; 70: 919–926. DOI:10.3168/jds.S0022-0302(87)80095-4; Kitazawa H., Mataumura K., Itoh T., Yamauchi T. Interferon induction in murine peritoneal macrophage by stimulation with Lactobacillus acidophilus. Microbiol Immunol 1992; 36: 311–315. DOI:10.1111/j.1348-0421.1992.tb01668.x; Kumura H., Tanoue Y., Tsukahara M., Tanaka T., Shimazaki K. Screening of dairy yeast strains for probiotics applications. J Dairy Sci 2004; 87: 4050–4056. DOI:10.3168/jds.S0022-0302(04)73546-8; Figler M., Mózsik G., Schaffer B., Gasztonyi B., Ács P., Szili B. et al. Effect of special Hungarian probiotic kefir on faecal microflora. World J Gastroenterol 2006; 12(7): 1129–1132. DOI:10.3748/wjg.v12.i7.1129; Thoreux K., Schmucker D.L. Kefir Milk Enhances Intestinal Immunity in Young but Not Old Rats. J Nutr 2001; 131: 807–812.; Lopitz-Otsoa F., Remenleria A., Elguezabal N., Garaizar J. Kefir: a symbiotic yeasts-bacteria community with alleged healthy capabilities. Rev Iberoam Micol 2006; 23: 67–74.; Bayless T.M., Huang S.-S. Inadequate intestinal digestion of lactose. Am J Clin Nutr 1969; 22: 250–256.; Goodenough E.R., Kleyn D.H. Influence of viable yogurt microflora on digestion of lactose by the rat. J Dairy Sci 1976; 59: 601–606.; Kim H.S., Gilliland S.E. Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans. J Dairy Sci 1983; 66: 959–966.; Kolars J.C., Levitt M.D., Aouji M., Savaiano D.A. Yogurt – An autodigesting source of lactose. N Engl J Med 1984; 310: 1–3.; Oppenheim J.J., Togawa A., Chedid L., Mizel S. Components of microbacteria and muramyl dipeptide with adjuvant activity induced lymphocyte activating factor. Cell Immunol 1980; 50: 71–81.; Forster K.A. The vitamin content of the sour milk products, yoghurt, kefir and saya. Biochem Z 1931; 236: 276–297.; Tufano M.A., Cipollaro de l’Ero G., Ianniello R., Galdiero M., Galdiero F. Protein A and other surface components of Staphylococcus aureus stimulate production of IL-1 alpha, IL-4, IL-6, TNF and IFN-gamma. Eur Cytokine Netw 1991; 2(5): 361–366.; Goulet J., Saucier L., Moineau S. Stimulation of the non-specific immune response of mice by fermented milks. In: National Yogurt Association, ed. Yogurt: nutritional and health properties. McLean, VA: Kirby Lithographics, 1989: 187–200.; Mann G. V., Spoerry A. Studies of a surfactant and cholesteremia in the Maasai. Am J Clin Nutr 1974; 27: 464–469.; Mann G.V. A factor in yogurt which lowers cholesteremia in man. Atherosclerosis 1977; 26: 335–340.; Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V. et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 2011; 94: 3288–3294. DOI:10.3168/jds.2010-4128; Sayon-Orea C., Martínez-González M.A., Ruiz-Canela M., Bes-Rastrollo M. Associations between yogurt consumption and weight gain and risk of obesity and metabolic syndrome: A systematic review. Adv Nutr 2017; 8: 146S–154S. DOI:10.3945/an.115.011536; Reddy G.V., Friend B.A., Shahani K.M., Farmer R.E. Antitumor activity of yogurt components. J Food Prot 1983; 46: 8–11.; Ayebo A.D., Shahani K.M., Dam R. Antitumor component(s) of yogurt: Fractionation. J Dairy Sci 1981; 64: 2318–2323.; Хавкин А.И., Федотова О.Б., Волынец Г.В., Кошкарова Ю.А., Пенкина Н.А., Комарова О.Н. Результаты проспективного сравнительного открытого рандомизированного исследования по изучению эффективности йогурта, обогащенного пребиотиками и пробиотиками, у детей раннего возраста, перенесших острую респираторную инфекцию. Вопросы детской диетологии 2019; 17(1): 29–37. DOI:10.20953/1727-5784-2019-1-29-37; https://www.ped-perinatology.ru/jour/article/view/1030

الاتاحة: https://www.ped-perinatology.ru/jour/article/view/1030
https://doi.org/10.21508/1027-4065-2019-64-6-119-125

المؤلفون: S. V. Belmer, G. V. Volynets, А. V. Gorelov, M. M. Gurova, A. A. Zvyagin, E. A. Kornienko, V. P. Novikova, D. V. Pechkurov, V. F. Privorotskiy, A. A. Tyazheva, R. A. Faizullina, A. I. Khavkin, S. I. Erdes, С. В. Бельмер, Г. А. Волынец, А. В. Горелов, М. М. Гурова, А. А. Звягин, Е. А. Корниенко, В. П. Новикова, Д. В. Печкуров, В. Ф. Приворотский, A. А. Тяжева, Р. А. Файзуллина, А. И. Хавкин, С. И. Эрдес

المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 65, № 4 (2020); 150-161 ; Российский вестник перинатологии и педиатрии; Том 65, № 4 (2020); 150-161 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2020-65-4

مصطلحات موضوعية: функциональный запор, functional disorders, regurgitations, colic, gastroesophageal reflux, functional dyspepsia, functional abdominal pain, irritable bowel syndrome, biliary dysfunction, functional constipation, функциональные расстройства, срыгивания, колики, гастроэзофагеальный рефлюкс, функциональная диспепсия, функциональная абдоминальная боль, синдром раздраженного кишечника, билиарная дисфункция

وصف الملف: application/pdf

Relation: https://www.ped-perinatology.ru/jour/article/view/1214/969; Vandenplas Y., Gutierrez-Castrellon P., Velasco-Benitez C., Palacios J., Jaen D., Ribeiro H. et al. Practical algorithms for managing common gastrointestinal symptoms in infants. Nutrition 2013; 29: 184-194. DOI: org/10.1016/j.nut.2012.08.008; Drossman D.A. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV. Gastroenterol 2016;150:1262-1279. DOI:10.1053/j.gastro.2016.02.032; Rosen R., Vandenplas Y., Singendonk M., Cabana M., DiLorenzo C, Gottrand F. et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2018; 66(3): 516-554. DOI:10.1097/MPG.0000000000001889; van Wjk M.P., Benninga M.A., Davidson G.P., Haslam R, Omari T.I. Small volumes of feed can trigger transient lower esophageal sphincter relaxation and gastroesophageal reflux in the right lateral position in infants. J Pediatr 2010; 156: 744-748, 748 e1. DOI:10.1016/j.jpeds.2009.11.006; Moon R.Y. SIDS and other sleep-related infant deaths: expansion of recommendations for a safe infant sleeping environment. Pediatrics 2011; 128:1030-1039. DOI:10.1542/peds.2011-2285; Horvath A., Dziechciarz P, Szajewska H. The effect of thick-ened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials. Pediatrics 2008; 122: e1268-e1277. DOI:10.1542/peds.2008-1900; Vandenplas Y., Gutierrez-Castrellon P., Velasco-Benitez C. Palacios, Jaen D., Ribeiro H. et al. Practical algorithms for managing common gastrointestinal symptoms in infants. Nutrition 2013; 29(1): 184-194. DOI:10.1016/j.nut.2012.08.008; Lightdale J.R., Gremse D.A. Gastroesophageal reflux: management guidance for the pediatrician. Section on Gastroenterology, Hepatology, and Nutrition. Pediatrics 2013; 131(5): e1684- e1695. DOI: https://doi.org/10.1542/peds.2013-0421; Moore D.J., Tao B.S., Lines D.R., Hirte C. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr 2003; 143(2): 219-223. DOI:10.1067/S0022-3476(03)00207-5; Benninga S., Nurko M.A., Faure C., Hyman P.E., James-Rob-erts I.S., Schechter N.L. Childhood Functional Gastrointestinal Disorders: Neonate/Toddler. Gastroenterol 2016; 150(6): 1443-1455. DOI:10.1053/j.gastro.2016.02.016.; Shergill-Bonner R. Infantile colic: practicalities of management, including dietary aspects. J Fam Health Care 2010; 20: 206-209.; James-Roberts I.S., Alvarez M., Hovish K. Emergence of a developmental explanation for prolonged crying in 1- to 4-month-old infants: review of the evidence. J Pediatr Gastroenterol Nutr 2013; 57(Suppl 1):S30-S36. DOI:10.1097/01.mpg.0000441932.07469.1b; Vik T., Grote V., Escribano J., Socha J., Verduci E., Fritsch M. et al. European Childhood Obesity Trial Study Group. Infantile colic, prolonged crying and maternal postnatal depression. Acta Paediatr 2009; 98(8): 1344-1348. DOI:10.1111/j.1651-2227.2009.01317.x.; Szajewska H, Gyrczuk E, Horvath A. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebocontrolled trial. J Pediatr 2013; 162: 257-262. DOI:10.1016/j.jpeds.2012.08.004; Savino F, Cordisco L, Tarasco V., PalumeriE, CalabreseR., Og-gero R et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 2010; 126: e526-e533. DOI:10.1542/peds.2010-0433; Hyman P.E., Milla P.J., BenningaM.A., Davidson G.P., Fleish-er D.F., Taminiau J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterol 2006; 130: 15191526. DOI:10.1053/j.gastro.2005.11.065.; Kramer E.A., den Hertog-Kuijl J.H., van den Broek L.M., van Leengoed E., Bulk A.M., Kneepkens C.M., Benninga M.A. Defecation patterns in infants: a prospective cohort study. Arch Dis Child 2015; 100: 533-536. DOI: org/10.1136/archdis-child-2014-307448; van Tilburg M.A., Hyman P.E., Walker L., Rouster A., Pals-son O.S., Kim S.M., Whitehead W.E. Prevalence of functional gastrointestinal disorders in infants and toddlers. J Pediatr 2015; 166: 684-689. DOI: org/10.1016/j.jpeds.2014.11.039; Hyams J.S., Di Lorenzo S., Saps M., Shulman R.J., Staia-no A., van Tilburg M. Functional gastrointestinal disorders: child/adolescent. Gastroenterol 2016; 150: 1456-1468. DOI:10.1053/j.gastro.2016.02.015; Пиманов С.И., Силивончик Н.Н. Римские IV рекомендации по диагностике и лечению функциональных гастроэнтерологических расстройств: Пособие для врачей. М.: Практическая медицина, 2016; 136-137.; Kaul A., Kaul K. Cyclic vomiting syndrome: a functional disorder. Pediatr Gastroenterol Hepatol Nutr 2015; 18(4): 224229. DOI:10.5223/pghn.2015.18.4.224; Romano C., Dipasquale V., Rybak A., Comito D., Borrelli O. An overview of the clinical management of cyclic vomiting syndrome in childhood. Curr Med Res Opin 2018; 34(10): 1785— 1791. DOI:10.1080/03007995.2018.1445983; Li B.U., Lefevre F., Chelimsky G.G. Boles R.B., Nelson S.P., Lewis D.W. et al. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Consensus Statement on the Diagnosis and Management of Cyclic Vomiting Syndrome. J Pediatr Gastroenterol Nutr 2008; 47(3): 379— 393. DOI:10.1097/MPG.0b013e318173ed39; Белоусова Е.Д. Циклическая рвота. Российский вестник перинатологии и педиатрии 2011; 6: 63-65.; Камалова А.А., Шакирова А.Р. Синдром циклической рвоты. Вопросы детской диетологии 2013; 11(6): 69-71.; Madani S., Cortes O., Thomas R. Cyproheptadine Use in Children With Functional Gastrointestinal Disorders. J Pediatr Gastroenterol Nutr 2016; 62(3): 409-413. DOI:10.1097/MPG.0000000000000964.; Боулс Р. Эффективность комбинированной терапии с применением коэнзима Q10, L-карнитина и ами-триптилина в лечении синдрома циклической рвоты и сопутствующих функциональных расстройств. Российский вестник перинатологии и педиатрии 2012; 4(2):105—111.; https://www.ped-perinatology.ru/jour/article/view/1214

الاتاحة: https://www.ped-perinatology.ru/jour/article/view/1214
https://doi.org/10.21508/1027-4065-2020-65-4-150-161

المؤلفون: I. N. Skidan, A. E. Gulyaev, S. V. Belmer, И. Н. Скидан, А. Е. Гуляев, С. В. Бельмер

المساهمون: I.N. Skidan is the head of the scientific department of Bibicall-RUS Company, the exclusive distributor of infant adapted formulae based on whole goat milk in the Russian Federation, A.E. Gulyaev and S.V. Belmer confirm the absence of conflict of interests and financial support, which must be reported., И.Н. Скидан является руководителем научного отдела компании «БИБИКОЛЬ РУС», эксклюзивного дистрибьютора детских адаптированных смесей на основе цельного козьего молока в Российской Федерации, А.Е. Гуляев и С.В. Бельмер подтверждают отсутствие конфликта интересов и финансовой поддержки, о которых необходимо сообщить.

المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 64, № 3 (2019); 37-49 ; Российский вестник перинатологии и педиатрии; Том 64, № 3 (2019); 37-49 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2019-64-3

مصطلحات موضوعية: Orafti®Synergy1, adapted infant formula adapted, oligosaccharides of breast milk, inulin, oligofructose, детские адаптированные смеси, олигосахариды грудного молока, инулин, олигофруктоза

وصف الملف: application/pdf

Relation: https://www.ped-perinatology.ru/jour/article/view/891/783; Victora C.G., Bahl R., Barros A.J., França G.V., Horton S., Krasevec J. et al. Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong effect. Lancet 2016; 387: 475–490. DOI:10.1016/S0140-6736(15)01024-7; Hauck F.R., Thompson J.M., Tanabe K.O., Moon R.Y., Vennemann M.M. Breastfeeding and reduced risk of sudden infant death syndrome: A meta-analysis. Pediatrics 2011; 128: 103–110. DOI:10.1542/peds.2010-3000; Quigley M.A., Hockley C., Carson C., Kelly Y., Renfrew M.J., Sacker A. Breastfeeding is associated with improved child cognitive development: A population-based cohort study. J Pediatr 2012; 160: 25–32. DOI:10.1016/j.jpeds.2011.06.035; Horta B., Victora C. Long-term effects of breastfeeding: a systematic review. Geneva: World Health Organization, 2013; 74.; Gluckman P.D., Hanson M.A., Buklijas T. A conceptual framework for the developmental origins of health and disease. J Dev Orig Health Dis 2010; 1(1): 6–18. DOI:10.1017/ S2040174409990171; Bianco-Miotto T., Craig JM., Gasser YP., van Dijk S.J., Ozanne S.E. Epigenetics and DOHaD: from basics to birth and beyond. J Dev Orig Health Dis 2017; 8(5): 513–519. DOI:10.1017/S2040174417000733; Woo Baidal J.A., Locks L.M., Cheng, E.R., Blake-Lamb T.L., Perkins M.E., Taveras E.M. Risk factors for childhood obesity in the first 1,000 days: a systematic review. Am J Prev Med 2016; 50(6): 761–779. DOI:10.1016/j.amepre.2015.11.012; Goldman A.S. Future research in the immune system of human milk. J Pediatr 2019; 206: 274–279. DOI:10.1016/j. jpeds.2018.11.024; Martin R., Nauta A.J., Ben Amor K., Knippels L.M., Knol J., Garssen J. Early life: gut microbiota and immune development in infancy. Benef Microbes 2010; 1(4): 367–382. DOI:10.3920/BM2010.0027; Collins S.M., Surette M., Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012; 10(11): 735–742. DOI:10.1038/nrmicro2876.; Bremel R.D. University of Wisconsin and from Handbook of Milk Composition. Academic Press, 1995; 344.; Park Y.W., Juarez M., Ramos M., Haenlein G.F.W. Physicochemical characteristics of goat and sheep milk. Small Ruminant Res 2007; 68: 88–113. DOI: org/10.1016/j.smallrumres.2006.09.013; Messer M., Mossop G.S. Milk carbohydrates of marsupiais. I. Partial separation and characterisation of neutral milk oligosaccharides of the Eastern grey kangaroo. Aust J Biol Sci 1977; 30: 379–388. DOI:10.1071/BI9770379; Urashima T., Arita M., Yoshida M., Nakamura S., Arai I., Saito T. et al. Chemical characterisation of the oligosaccharides in hooded seal (Cystophora cristata) and Australian fur seal (Arctocephalus pusillus doriferus) milk. Comp Biochem Physiol B Biochem Mol Biol 2001; 128(2): 307–323. DOI: org/10.1016/S1096-4959(00)00327-4; Vandenplas Y. Lactose intolerance. Asia Pac J Clin Nutr 2015; 24 (Suppl 1): 9–13. DOI:10.6133/apjcn.2015.24.s1.02; Venema K. Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides. Int Dairy J 2012; 22(2): 123–140. DOI: org/10.1016/j.idairyj.2011.10.011; Ito M., Rimura M. Influence of lactose on faecal microflora in lactose maldigesters. Microb Ecol Health Dis 1993; 6: 73– 76. DOI: org/10.3109/08910609309141564; Gibson G.R., Hutkins R., Sanders M.E., Prescott S.L., Reimer R.A., Salminen S.J., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 2017; 14: 491–502. DOI:10.1038/nrgastro.2017.75; Макарова Е.Г., Нетребенко О.К., Украинцев С.Е. Олигосахариды грудного молока: история открытия, структура и защитные функции. Педиатрия. Журнал им. Г.Н. Сперанского 2018; 97(4): 152–160. [Makarova E.G., Netrebenko O.K., Ukrainzev S.E. Oligosaccharides of breast milk: history of opening, structure and protective functions. Pediatria 2018; 97(4): 152–160. (in Russ)]; Blank D., Dotz V., Geyer R., Kunz C. Human milk oligosaccharides and Lewis blood group: Individual high-throughput sample profiling to enhance conclusions from functional studies. Adv Nutr 2012; 3: 440–449. DOI:10.3945/an.111.001446; Prieto P. Profiles of human milk oligosaccharides and production of some human milk oligosaccharides in transgenic animals. Adv Nutr 2012; 3: 456–464. DOI:10.3945/ an.111.001529; Хавкин А.И. Влияние пребиотиков на иммунную систему. Эффективная фармакотерапия. 2014; 42: 34–39. [Khavkin A.I. Impact of prebiotics on immune system. Effektivnaya farmakoterapia 2014; 42: 34–39. (in Russ)]; McGuire M.K., Meehan C.L., McGuire M.A., Williams J.E., Foster J., Sellen D.W. et al. What’s normal? Oligosaccharide concentrations and profiles in milk produced by healthy women vary geographically. Am J Clin Nutr 2017; 105: 1086– 1100. DOI:10.3945/ajcn.116.139980; Oliveira D.L., Wilbey R.A., Grandison A.S., Roseiro L.B. Milk oligosaccharides: A review. Inter J Dairy Technol 2015; 68(3): 305–321. DOI:10.1111/1471-0307.12209; Meyrand M., Dallas D.C., Caillat H., Bouvier F., Martin P., Barile D. Comparison of milk oligosaccharides between goats with and without the genetic ability to synthesize αs1-casein. Small Rumin Res 2013; 113(2–3): 411–420.; Montreuil J. The saga of human milk gynolactose. In: B. Renner, G. Sawatzki (eds). New Perspectives in Infant Nutrition. Stuttgart, New York: Georg Thieme Verlag, 1992; 3–11.; Polonovski M., Lespagnol A. Sur deux nouveaux sucres du lait de femme, le gynolactose et 1’allolactose. Compte Rendu de l’Academie des Sciences 1931; 192: 1319–1320.; Polonowski M., Montreuil J. Etude chromatographique des polyosides du lait de Femme. C R Acad Sci Paris 1954; 238: 2263–2264.; Gyorgy P., Norris R.F., Rose C.S. Bifidus factor. I. A variant of Lactobacillus bifidus requiring a special growth factor. Arch Biochem Biophys 1954; 48(1): 193–201.; Goehring K.C., Kennedy A.D., Prieto P.A., Buck R.H. Direct evidence for the presence of human milk oligosaccharides in the circulation of breastfed infants. PLoS ONE 2014; 9: e101692. DOI:10.1371/journal.pone.0101692; Craft K.M., Thomas H.C., Townsend S.D. Interrogation of human milk oligosaccharide fucosylation patterns for antimicrobial and antibiofilm trends in group B streptococcus. ACS Infect Dis. 2018; DOI:10.1021/acsinfecdis.8b00234; Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods. Off J Eur Union 2017; 351: 72–201.; Kajzer J., Oliver J., Marriage B. Gastrointestinal tolerance of formula supplemented with oligosaccharides. FASEB J 2016; 30: 671.; Marriage B.J., Buck R.H., Goehring K.C., Oliver J.S., Williams J.A. Infants fed a lower calorie formula with 2’FL show growth and 2’FL uptake like breast-fed infants. J Pediatr Gastroenterol Nutr 2015; 61: 649–658. DOI:10.1097/ MPG.0000000000000889; Morrow A.L., Ruiz-Palacios G.M., Altaye M., Guerrero M.L., Meinzen-Derr J.K., Farkas T. et al. Human milk oligosaccharides are associated with protection against diarrhea in breastfed infants. J Pediatr 2004; 145: 297–303. DOI:10.1016/j. jpeds.2004.04.054; Stepans M.B., Wilhelm S.L., Hertzog M., Rodehorst T.K., Blaney S., Clemens B., et al. Early consumption of human milk oligosaccharides is inversely related to subsequent risk of respiratory and enteric disease in infants. Breastfeed Med 2006; 1: 207–215. DOI:10.1089/bfm.2006.1.207; Guan N., Chen R. Recent Technology Development for the Biosynthesis of Human Milk Oligosaccharide. Recent Pat Biotechnol 2018; 12(2): 92–100. DOI:10.2174/1872208311 666170531110721; Thum C., Roy N.C., McNabb W.C., Otter D.E., Cookson A.L. In Vitro Fermentation of caprine milk oligosaccharides by bifidobacteria isolated from breast-fed infants. Gut Microbes 2015; 6(6): 352–363. DOI:10.1080/19490976.2015.1105425; Daddaoua A., Puerta V., Requena P., Martínez-Férez A., Guadix E., de Medina F.S. et al. Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. J Nutr 2006; 136(3): 672–676. DOI:10.1093/jn/136.3.672; Lara-Villoslada F., Debras E., Nieto A., Concha A., Gálvez J., López-Huertas E. et al. Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clin Nutr 2006; 25(3): 477– 488. DOI:10.1016/j.clnu.2005.11.004; Kim H.-H., YunS-S., Oh C.-H., Yoon S.S. Galactooligosaccharide and sialyllactose content in commercial lactose powders from goat and cow milk. Korean J Food Sci Anim Resour 2015; 35(4): 572–576. DOI:10.5851/kosfa.2015.35.4.572; Скидан И.Н., Казначеев К.С., Кирилова А.В., Гуляев А.Е. Функциональные пищевые нутриенты в составе детских адаптированных смесей на основе цельного козьего молока. Вопросы практической педиатрии 2015; 4: 38–48. [Skidan I.N., Kaznacheev K.S., Kirillova A.V., Gulyaev A.E. The functional dietary components in infant formulas from goat milk. Voprosy Prakticheskoi Pediatrii 2015; 4: 38–48. (in Russ)]; Knol J., Scholtens P., Kafka C., Steenbakkers J., Gro S., Helm K. et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 2005; 40(1): 36–42.; Технический Регламент Таможенного союза «О безопасности молока и молочной продукции» (ТР ТС 033/2013). http://24.rospotrebnadzor.ru/links/NormMetodObesp/TehRegTS/.; Azagra-Boronat I., Massot-Cladera M., Knipping K., van’t Land B., Stahl B.,Garssen J. et al. Supplementation with 2’- FL and scGOS/lcFOS ameliorates rotavirus-induced diarrhea in suckling rats. Front Cell Infect Microbiol 2018; 8: 372. DOI:10.3389/fcimb.2018.00372; Roberfroid M. Prebiotics: the concept revisited. J Nutr 2007; 137(3,2): 830–837. DOI:10.1093/jn/137.3.830S; Kelly G. Inulin-type prebiotics – a review: part 1. Altern Med Rev 2008; 13(4): 315–329.; Firmansyah A., Chongviriyaphan N., Dillon D.H., Khan N.C., Morita T., Tontisirin K. et al. Fructans in the first 1000 days of life and beyond, and for pregnancy. Asia Pac J Clin Nutr 2016; 25(4): 652–675. DOI:10.6133/apjcn.092016.02; Vos A., M’Rabet L., Stahl B., Boehm G., Garssen J. Immunemodulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates. Crit Rev Immunol 2007; 27: 97–140.; Mensink M.A., Frijlink H.W., van der Voort Maarschalk K., Hinrichs W.L. Inulin, a flexible oligosaccharide I: Review of its physicochemical characteristics. Carbohydr Polym 2015; 130: 405–419. DOI:10.1016/j.carbpol.2015.05.026; Closa-Monasterolo R., Gispert-Llaurado M., Luque V., Ferre N., Rubio-Torrents C., Zaragoza-Jordana M. et al. Safety and efficacy of inulin and oligofructose supplementation in infant formula: results from a randomized clinical trial. Clin Nutr 2013; 32(6): 918–927. DOI:10.1016/j.clnu.2013.02.009; Rao S., Srinivasjois R., Patole S. Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials. Arch Pediatr Adolesc Med 2009; 163(8): 755– 764. DOI:10.1001/archpediatrics.2009.94; Kim S. H., Lee D. H., Meyer D. Supplementation of baby formula with native inuline has a prebiotic effect in formula-fed babies. Asia Pac J Clin Nutr 2007; 16: 172–177.; Lomax A.R., Calder P.C. Prebiotics, immune function, infection and inflammation: a review of the evidence. Br J Nutr 2009; 101(5): 633–658. DOI:10.1017/S0007114508055608; Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly-Y. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569–573. DOI:10.1126/science.1241165; Vogt L., Ramasamy U., Meyer D., Pullens G., Venema K., Faas M.M. et al. Immune modulation by different types of β2→1-fructans is toll-like receptor dependent. PLoS One 2013; 8: e68367. DOI:10.1371/journal.pone.0068367; Казначеев К.С., Казначеева Л.Ф., Скидан И.Н., Чеганова Ю.В. Влияние молочной смеси с пребиотиками на основе новозеландского козьего молока на формирование здорового пищеварения у детей первого года жизни. Лечащий врач 2015; 9: 37–41. [Kaznacheev K.S., Kaznacheyeva L.F. Skidan I.N., Cheganova Y.V. Influence of milk mixture based on goat’s milk with prebiotics on forming healthy digestion in children in their first year. Lechashii Vrach 2015; 9: 37–41. (in Russ)].; Богданова С.В., Сенцова Т.Б., Денисова С.Н., Ильенко Л.И., Ревякина В. А., Тарасова О.В., Черняки О.О. Метаболическая активность кишечной микрофлоры и характер сенсибилизации при различных видах вскармливания у здоровых детей. Рос вестн перинатол и педиатр 2015; 5: 135–142. [Bogdanova S.V., Sentsova T.B., Denisova S.N., Il’enko L.I., Revyakina V. А., Tarasova O.V., Chernyaki O.O. The metabolic activity of the enteric microflora and the pattern of sensitization in different types of feeding in healthy infants. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2015; 60(5): 135– 142. (in Russ)].; Белоусова О.Ю., Ганзий Е.Б. Опыт применения смеси «НЭННИ 1 с пребиотиками» у детей первого полугодия жизни с функциональными запорами. Здоровье ребенка 2018; 13(2.1): 7–15. [Belousova O.Yu., Ganziy E.B. Experience in the use of a mixture of «NANNI 1 with prebiotics in children of the first half of the year of life with functional constipation. Zdorov’e rebenka 2018; 13(2.1): 7–15. (in Russ)].; Feruś K., Drabińska N., Krupa-Kozak U., Jarocka-Cyrta E. Randomized, Placebo-Controlled, Pilot Clinical Trial to Evaluate the Effect of Supplementation with Prebiotic Synergy 1 on Iron Homeostasis in Children and Adolescents with Celiac Disease Treated with a Gluten-Free Diet. Nutrients 2018; 10(11): E1818. DOI:10.3390/nu10111818; Drabińska N., Jarocka-Cyrta E., Markiewicz L.H., Krupa-Kozak U. The Effect of Oligofructose-Enriched Inulin on Faecal Bacterial Counts and Microbiota-Associated Characteristics in Celiac Disease Children Following a Gluten-Free Diet: Results of a Randomized, Placebo-Controlled Trial. Nutrients 2018; 10(2): E201. DOI:10.3390/nu10020201; Drabińska N., Krupa-Kozak U., Ciska E., Jarocka-Cyrta E. Plasma profile and urine excretion of amino acids in children with celiac disease on gluten-free diet after oligofructose-enriched inulin intervention: results of a randomised placebocontrolled pilot study. Amino Acids 2018; 50(10): 1451–1460. DOI:10.1007/s00726-018-2622-7; Drabińska N., Krupa-Kozak U., Abramowicz P., Jarocka-Cyrta E. Effect of oligofructose-enriched inulin on vitamin D and E Status in children with celiac disease on a long-term gluten-free diet: A preliminary randomized, placebo-controlled nutritional intervention study. Nutrients 2018; 10(11): E1768. DOI:10.3390/nu10111768; Ho J., Reimer R.A., Doulla M., Huang C. Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial. Trials 2016; 17(1): 347. DOI:10.1186/s13063-016-1486-y; Aliasgharzadeh A., Khalili M., Mirtaheri E., Pourghassem Gargari B., Tavakoli F., Abbasalizad Farhangi M. et al. Combination of prebiotic inulin and oligofructose improve some of cardiovascular disease risk factors in women with type 2 diabetes: a randomized controlled clinical trial. Adv Pharm Bull 2015; 5(4): 507–514. DOI:10.15171/apb.2015.069; Dehghan P., Pourghassem Gargari B., Asghari Jafar-abadi M. Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized controlled clinical trial. Nutrition 2014; 30(4): 418–423. DOI:10.1016/j.nut.2013.09.005; Nicolucci A.C., Hume M.P., Martínez I., Mayengbam S., Walter J., Reimer R.A. Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterol 2017; 153(3): 711–722. DOI:10.1053/j. gastro.2017.05.055; Hume M.P., Nicolucci A.C., Reimer R.A. Prebiotic supplementation improves appetite control in children with overweight and obesity: a randomized controlled trial. Am J Clin Nutr 2017; 105(4): 790–799. DOI:10.3945/ajcn.116.140947; Valcheva R., Koleva P., Martínez I., Walter J., Gänzle M.G., Dieleman L.A. Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels. Gut Microbes 2018; 5: 1–24. DOI:10.1080/19490976.2018.1526583; Holloway L., Moynihan S., Abrams S.A., Kent K., Hsu A.R., Friedlander A.L. Effects of oligofructose-enriched inulin on intestinal absorption of calcium and magnesium and bone turnover markers in postmenopausal women. Br J Nutr 2007; 97: 365–372. DOI:10.1017/S000711450733674X; Smith A.P., Sutherland D., Hewlett P. An investigation of the acute effects of oligofructose-enriched inulin on subjective wellbeing, mood and cognitive performance. Nutrients 2015; 7(11): 8887–8896. DOI:10.3390/nu7115441; https://www.ped-perinatology.ru/jour/article/view/891

الاتاحة: https://www.ped-perinatology.ru/jour/article/view/891
https://doi.org/10.21508/1027-4065-2019-64-3-37-50

المؤلفون: S. V. Belmer, С. В. Бельмер

المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 61, № 4 (2016); 43-48 ; Российский вестник перинатологии и педиатрии; Том 61, № 4 (2016); 43-48 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2017-4-4

مصطلحات موضوعية: антиканцерогенный эффекты, complementary food, fruit juices, apple juice, polyphenols, antioxidant, anti-atherogenic, anti-cancer effects, прикорм, фруктовые соки, яблочный сок, полифенолы, антиоксидантный, антиатерогенный

وصف الملف: application/pdf

Relation: https://www.ped-perinatology.ru/jour/article/view/351/380; Национальная программа оптимизации вскармливания детей первого года жизни в Российской Федерации. Под ред. А. А. Баранова, В. А. Тутельяна. М., 2011; 68. (The national program of feeding optimization of children of the first year of life in the Russian Federation. А. А. Baranov, V. А. Tutel’yan (eds). Moscow, 2011; 68.); Frei B., Higdon J. V. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 2003; 133: 10: 3275S–3284S.; Koutsos A., Tuohy K. M., Lovegrove J. A. Apples and cardiovascular health — is the gut microbiota a core consideration? Nutrients 2015; 7: 3959–3998.; Ozdal T., Sela D. A., Xiao J. et al. The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients 2016; 8: 78–114.; Blaut M., Schoefer L., Braune A. Transformation of flavonoids by intestinal microorganisms. Int J Vitam Nutr Res 2003; 73: 2: 79–87.; Souci S. W., Fachmann W., Kraut H., revised by Kirchhoff E. Food composition and nutrition tables, based on the 6th edition. Stuttgart: Medpharm GmbH Scientific Publishers, 2005; 226.; Kahle K., Kraus M., Richling E. Polyphenol profiles of apple juices. Mol Nutr Food Res 2005; 49: 797–806; Vrhovsek U., Rigo A., Tonon D., Mattivi F. Quantitation of polyphenols in different apple varieties. J Agric Food Chem 2004; 52: 6532–6538.; Gerhauser C. Cancer Chemopreventive Potential of Apples, Apple Juice, and Apple Components. Planta Med 2008; 74: 1608–1624.; Wojdylo A., Oszmianski J., Laskowski P. Polyphenolic compounds and antioxidant activity of new and old apple varieties. J Agric Food Chem 2008; 56: 6: 520–530.; Hyson D. A. A Comprehensive Review of Apples and Apple Components and Their Relationship to Human Health. Adv Nutr 2011; 2: 408–420.; Sun J., Chu Y., Wu X., Liu R. H. Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem 2002; 50: 7449–7454.; Lee K., Kim Y., Kim D. et al. Major phenolics in apple and their contribution to the total antioxidant capacity. J Agric Food Chem 2003; 51: 6516–6520.; Escarpa A., Gonzalez M. High-performance liquid chromatography with diode-array detection for the performance of phenolic compounds in peel and pulp from different apple varieties. J Chromat 1998; 823: 331–337.; Boyer J., Liu R. H. Apple phytochemicals and their health benefits. Nutrition J 2004; 3: 5–20.; Arts I. C. W., Hollman P. C. H. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005; 81: Suppl: 317S–325S.; Osada K., Suzuki T., Kawakami Y. et al. Dose-dependent hypocholesterolemic actions of dietary apple polyphenol in rats fed cholesterol. Lipids 2006; 41: 133–139.; Osada K., Funayama M., Fuchi S. et al. Effects of dietary procyanidins and tea polyphenols on adipose tissue mass and fatty acid metabolism in rats on a high fat diet. J Oleo Sci 2006; 55: 79–89.; Murase T., Nagasawa A., Suzuki J. et al. Beneficial effects of tea catechins on diet- induced obesity: Stimulation of lipid catabolism in the liver. Int J Obes 2002; 26: 1459–1464.; Ohta Y., Sami M., Kanda T. et al. Gene expression analysis of the anti-obesity effect by apple polyphenols in rats fed a high fat diet or a normal diet. J Oleo Sci 2006; 55: 305–314.; Vidal R., Hernandez-Vallejo S., Pauquai T. et al. Apple procyanidins decrease cholesterol esterification and lipoprotein secretion in Caco-2/TC7 enterocytes. J Lipid Res 2005; 46: 258–268.; Ikeda I., Imasato Y., Sasaki E. et al. Tea catechins decrease micellar solubility and intestinal-absorption of cholesterol in rats. Biochim Biophys Acta 1992; 1127: 141–146.; Lam C. K., Zhang Z. S., Yu H. J. et al. Apple polyphenols inhibit plasma CETP activity and reduce the ratio of non-HDL to HDL cholesterol. Mol Nutr Food Res 2008; 52: 950–958.; Garcia-Diez F., Garcia-Mediavilla V., Bayon J. E., Gonzalez-Gallego J. Pectin feeding influences fecal bile acid excretion, hepatic bile acid and cholesterol synthesis and serum cholesterol in rats. J Nutr 1996; 126: 1766–1771.; Gonzalez M., Rivas C., Caride B. et al. Effects of orange and apple pectin on cholesterol concentration in serum, liver and faeces. J Physiol Biochem 1998; 54: 99–104.; Hanhineva K., Törrönen R., Bondia-Pons I. et al. Impact of Dietary Polyp henols on Carbohydrate Metabolism. Int J Mol Sci 2010; 11: 1365–1402.; Cermak R., Landgraf S., Wolffram S. Quercetinglucosides inhibit glucose uptake into brushborder-membrane vesicles of porcine jejunum. Br J Nutr 2004; 91: 849–855.; Kobayashi Y., Suzuki M., Satsu H. et al. Green tea polyphenols inhibit the sodium- dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J Agric Food Chem 2000; 48: 5618–5623.; Shimizu M., Kobayashi Y., Suzuki M. et al. Regulation of intestinal glucose transport by tea catechins. Biofactors 2000; 13: 61–65.; Johnston K., Sharp P., Clifford M., Morgan L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett 2005; 579: 1653–1657.; Li J. M., Che C. T., Lau C. B. et al. Inhibition of intestinal and renal Na+-glucose cotransporter by naringenin. Int J Biochem Cell Biol 2006; 38: 985–995.; Song J., Kwon O., Chen S. et al. Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and Glucose. J Biol Chem 2002; 277: 15252–15260.; Davalos A., Fernandez-Hernando C., Cerrato F. et al. Red Grape Juice Polyphenols Alter Cholesterol Homeostasis and Increase. LDL-Receptor Activity in Human Cells In Vitro. J Nutr 2006; 136: 1766–1773.; Basu A. Berries: emerging impact on cardiovascular health. Nutr Rev 2010; 68: 3: 168–177.; Percival S. S., Bukowski J. F., Milner J. Bioactive food components that enhance gammadelta T cell function may play a role in cancer prevention. J Nutr 2008; 138: 1: 1–4.; Percival S. S. Grape Consumption Supports Immunity in Animals and Humans. J Nutr 2009; 139: 1801S–1805S.; Shankar S., Singh G., Srivastava R. K. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Frontiers in Bioscience (Journal and Virtual Library) 2007; 12: 12: 4839–4854.; Gatz S. A., Wiesmuller L. Take a break — resveratrol in action on DNA. Carcinogenesis 2008; 29: 2: 321–332.; Yoo M. A., Chung H. K., Kang M. H. Evaluation of physicochemical properties in different cultivar grape seed waste. Food Sci Biotechnol 2004; 13: 26–29.; Joseph J. A., Shukitt-Hale B., Willis L. M. Grape Juice, Berries, and Walnuts Affect Brain Aging and Behavior. J Nutr 2009; 139: 1813S–1817S.; Siddiq M. Plums and prunes. Handbook of Fruits and Fruit Processing. Y. H. Hui (ed.). Blackwell Publishing Professional, Iowa City, Iowa, USA, 2006; 553–564.; Bouayed J., Rammal H., Dicko A. et al. Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects. J Neurol Sc 2007; 262: 1–2: 77–84.; Bouayed J., Rammal H., Soulimani R. Oxidative stress and anxiety, relationship and cellular pathways. Oxidative Med Cellular Longevity 2009; 2: 63–67.; Dongowski G., Lorenz A. Unsaturated oligogalacturonic acids are generated by in vitro treatment of pectin with human faecal flora. Carbohydr Res 1998; 314: 237–244.; Dongowski G., Lorenz A., Proll A. The degree of methylation influences the degradation of pectin in the intestinal tract of rats and in vitro. J Nutr 2002; 132: 1935–1944.; Gulfi M., Arrigoni E., Amado R. The chemical characteristics of apple pectin influence its fermentability in vitro. Lwt Food Sci Tech 2006; 39: 1001–1004.; Brouns F., Theuwissen E., Adam A. et al. Cholesterol-lowering properties of different pectin types in mildly hyper-cholesterolemic men and women. Eur J Clin Nutr 2012; 66: 591– 599.; Spiller G. A., Chernoff M. C., Hill R. A. et al. Effect of purified cellulose, pectin, and a low- residue diet on fecal volatile fattyacids, transit-time, and fecal weight in humans. Am J Clin Nutr 1980; 33: 754–759.; Schwartz S. E., Levine R. A., Singh A. et al. Sustained pectin ingestion delays gastric- emptying. Gastroenterol 1982; 83: 812–817.; Tamura M., Nakagawa H., Tsushida T. et al. Effect of pectin enhancement on plasma quercetin and fecal flora in rutinsupplemented mice. J Food Sci 2007; 72: S648–S651.; Nishijima T., Iwai K., Saito Y. et al. Chronic ingestion of apple pectin can enhance the absorption of quercetin. J Agric Food Chem 2009; 57: 2583–2587.; Titgemeyer E. C., Bourquin L. D., Fahey G. C., Garleb K. A. Fermentability of various fiber sources by human fecal bacteria invitro. Am J Clin Nutr 1991; 53: 1418–1424.; Barry J. L., Hoebler C., Macfarlane G. T. et al. Estimation of the fermentability of dietary fiber in-vitro — a european interlaboratory study. Br J Nutr 1995; 74: 303–322.; Bourquin L. D., Titgemeyer E. C., Fahey G. C. Fermentation of various dietary fiber sources by human fecal bacteria. Nutr Res 1996; 16: 1119–1131.; Конь И. Я., Гмошинская М. В., Георгиева О. В. и др. Использование соков прямого отжима в питании детей первого года жизни. Рос вестн перинатол и педиатр 2015; 4: 125–130. (Kon’ I. Ya., Gmoshinskaya M. V., Georgieva O. V. et al.Use of juice of a direct extraction in food of children of the first year of life. Ros vestn perinatol i pediatr 2015; 4: 125–130.); Ferguson L. R. Antimutagens as cancer chemopreventive agents in the diet. Mutat Res 1994; 307: 395–410.; Hensel A., Meier K. Pectins and xyloglucans exhibit antimutagenic activities against nitroaromatic compounds. Planta Med 1999; 65: 395–399.; Ferguson L. R., Zhu S., Kestell P. Contrasting effects of nonstarch polysaccharide and resistant starch-based diets on the disposition and excretion of the food carcinogen, 2‑amino-3‑methylimidazo [4,5‑f] quinoline (IQ), in a rat model. Food Chem Toxicol 2003; 41: 785–792.; Kestell P., Zhu S., Ferguson L. R. Mechanisms by which resistant starches and non-starch polysaccharide sources affect the metabolism and disposition of the food carcinogen, 2‑amino-3‑methylimidazo [4,5‑f] quinoline. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 802: 201–210.; Pohl C., Will F., Dietrich H., Schrenk D. Cytochrome P450 1A1 expression and activity in Caco-2 cells: modulation by apple juice extract and certain apple polyphenols. J Agric Food Chem 2006; 54: 10262–10268.; Gerhauser C., Klimo K., Heiss E. et al. Mechanism-basedin vitroscreening of potential cancer chemopreventive agents. Mutat Res 2003; 523–524: 163–172.; Zessner H., Pan L., Will F. et al. Fractionation of polyphenolenriched apple juice extracts to identify constituents with cancer chemopreventive potential. Mol Nutr Food Res 2008; 52: 1: S28–44.; Feskanich D., Ziegler R. G., Michaud D. S. et al. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 2000; 92: 1812–1823.; Michels K. B., Giovannucci E., Chan A. T. et al. Fruit and vegetable consumption and colorectal adenomas in the Nurses' Health Study. Cancer Res 2006; 66: 3942–3953.; Deneo-Pellegrini H., De Stefani E., Ronco A. Vegetables, fruits, and risk of colorectal cancer: a case-control study from Uruguay. Nutr Cancer 1996; 25: 297–304.; Lee S. Y., Choi K. Y., Kim M. K. et al. The relationship between intake of vegetables and fruits and colorectal adenoma-carcinoma sequence. Korean J Gastroenterol 2005; 45: 23– 33.; Gallus S., Talamini R., Giacosa A. et al. Does an apple a day keep the oncologist away? Ann Oncol 2005; 16: 1841–1844.; Cook J. D., Monsen E. R. Vitamin C, the common cold, and iron absorption. Amer J Clin Nutrit 1977; 30: 235–241.; https://www.ped-perinatology.ru/jour/article/view/351

الاتاحة: https://www.ped-perinatology.ru/jour/article/view/351
https://doi.org/10.21508/1027-4065-2016-61-4-43-48

المؤلفون: S. V. Bel'mer, T. V. Gasilina, С. В. Бельмер, Т. В. Гасилина

المصدر: Current Pediatrics; Том 12, № 3 (2013); 12-17 ; Вопросы современной педиатрии; Том 12, № 3 (2013); 12-17 ; 1682-5535 ; 1682-5527

مصطلحات موضوعية: безглютеновая диета, pathogenesis, treatment, gluten free diet, патогенез, лечение

وصف الملف: application/pdf

Relation: https://vsp.spr-journal.ru/jour/article/view/325/228; Filatov N. F. Semiotika i diagnostika detskikh boleznei. Ruko vodstvo dlya vrachei [Semiotics and diagnosis of child diseases]. 1905. 681 p.; Wieser H., Seilmleier W. Prolamins. Getreide Mehl. Brot. 1991; 45: 35–38.; Sapone A., Bai J. C., Ciacci C., Dolinsek J., Green P. H. R., Hadjivassiliou M., Kaukinen K., Rostami K., Sanders D. S., Schumann M., Ullrich R., Villalta D., Volta U., Catassi C., Fasano A. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Medicine. 2012; 10: 13.; Fasano A. European and North American populations should be screened for coeliac disease. Gut. 2003; 52: 168–169.; Corrao G., Corazza G. R., Bagnardi V., Brusco G., Ciacci C., Cottone M., Sategna Guidetti C., Usai P., Cesari P,. Pelli M. A., Loperfido S., Volta U., Calabro A., Certo M. Club del Tenue Study Group. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001; 358 (9279): 356–361.; Ivarsson A., Hernell O., Stenlund H., Persson L. A. Breastfeeding protects against celiac disease. Am. J. Clin. Nutr. 2002; 75: 914–921.; Troncone R., Scarcella A., Donatiello A. et al. Passage of gliadin into human breast milk. Acta. Paediatr. Scand. 1987; 76: 453–456.; Chirdo F. G., Rumbo M., Anon M. C. et al. Presence of high levels of non-degraded gliadin in breast milk from healthy mothers. Scand. J. Gastroenterol. 1998; 33: 1186–1192.; Hogen Esch C. E., Rosen A., Auricchio R. et al. PreventCD Study Group. The PreventCD Study design: towards new strategies for the prevention of coeliac disease. Eur. J. Gastroenterol. Hepatol. 2010; 22: 1424–1430.; ESPGHAN Committee on Nutrition. Breast feeding. A position paper by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2009; 49: 112–125.; Szajewska H., Chmielewska A., Piescik-Lech M., Ivarsson A., Kolacek S., Koletzko S., Mearin M. L., Shamir R., Auricchio R., Troncone R. PREVENTCD Study Group. Systematic review: early infant feeding and the prevention of coeliac disease. Aliment. Pharmacol. Ther. 2012; 36: 607–518.; Spaenij-Dekking L., Kooy-Winkelaar Y., van Veelen P., Drijfhout J. W., Jonker H. et al. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology. 2005; 129: 797–806.; Gass J., Bethune M. T., Siegel M., Spencer A., Khosla C. Combi nation enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology. 2007; 133: 472–480.; Cornell H. J., Macrae F. A., Melny J., Pizzey C. J., Cook F. et al. Enzyme therapy for management of coeliac disease. Scand. J. Gastroenterol. 2005; 40: 1304–1312.; Paterson B. M., Lammers K. M., Arrieta M. C., Fasano A., Meddings J. B. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Aliment. Pharmacol. Ther. 2007; 26: 757–766.; Siegel M., Khosla C. Transglutaminase 2 inhibitors and their thera peutic role in disease states. Pharmacol. Ther. 2007; 115: 232–245.; Bethune M. T., Khosla C. Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathogens. 2008; 4 (2–34): 1–16.; Collin P., Thorell L., Kaukinen K., Maki M. The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Aliment. Pharmacol. Ther. 2004; 19: 1277–1283.; Dewar D. H., Ciclitira P. J. Clinical studies on thresholds for gluten sensitivity in coeliac disease: Introduction. Proceedings of the 18th Meeting of Working Group on Prolamin Analysis and Toxity. Stockholm. 2003. P. 155–160.; https://vsp.spr-journal.ru/jour/article/view/325

الاتاحة: https://vsp.spr-journal.ru/jour/article/view/325
https://doi.org/10.15690/vsp.v12i3.676